Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Andy Moy
Analytical Development
Takeda Pharmaceutical Company Limited
Poster(s):
(W1130-02-13) Multi-Compartment In Vitro Dissolution Testing to Study the Potential Impact of API Changes on Drug-in-Capsule Absorption for Mobocertinib, a Weak Base with Complex pH-Dependent Solubility
Wednesday, November 12, 2025
11:30 AM - 12:30 PM
CT
